{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:50:51Z","timestamp":1773733851468,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop and validate a multifactorial machine learning model predicting thyroid cancer (TC) co-occurrence risk in breast cancer (BC) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective matched case-control study analyzed 400 BC patients (200 with co-occurring TC, 200 matched BC-only controls) diagnosed between 2012-2025. Predictors included demographic, clinical, hormonal, and tumor biological variables. After feature selection via LASSO regression to handle multicollinearity, four machine learning algorithms (logistic regression, random forest, XGBoost, SVM) were developed and optimized using Bayesian hyperparameter tuning with 5-fold cross-validation. Model performance was evaluated on a 30% independent test set using AUC-ROC, calibration curves, and decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multivariate analysis identified independent risk factors for TC co-occurrence: radiotherapy history (aOR = 3.42, 95% CI: 2.14\u20135.46), elevated TSH level (aOR = 2.01 per \u00b5IU\/mL, 95% CI: 1.65\u20132.45), ER-positive status (aOR = 2.47, 95% CI: 1.43\u20134.28), family history of TC (aOR = 3.05, 95% CI: 1.55\u20136.00), and younger age at BC diagnosis (aOR = 1.07 per year decrease, 95% CI: 1.04\u20131.10). The XGBoost model demonstrated superior discrimination (test AUC = 0.874, 95% CI: 0.836\u20130.934) compared to other algorithms, with 86.7% accuracy, 83.3% sensitivity, and 90.0% specificity. Notably, subgroup analysis revealed enhanced predictive performance in patients with a history of radiotherapy (AUC = 0.921). Decision curve analysis confirmed clinical utility across threshold probabilities (20\u201380%), showing a superior net benefit for personalized risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The XGBoost-based model integrates radiotherapy exposure, hormonal profiles, and tumor biology to stratify TC risk in BC patients. It offers a clinically applicable tool for personalized surveillance, balancing early detection with resource optimization. External validation is warranted before implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1772910","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:26:27Z","timestamp":1773725187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a multifactorial risk prediction model for breast cancer patients with co-occurring thyroid cancer: a retrospective matched case-control study"],"prefix":"10.3389","volume":"16","author":[{"given":"Junming","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Institute of Brain Function Rehabilitation and Imaging, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[{"name":"Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kepeng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songlin","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guocheng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Mastothyroid Vascular Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College","place":["Nanchong, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"70","author":"Sung","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S442707","article-title":"Thyroid hormone changes correlate to combined breast cancer with primary thyroid cancer","volume":"16","author":"Jin","year":"2024","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1186\/s12864-023-09854-9","article-title":"Unbalanced bidirectional causal association between thyroid cancer and ER-positive breast cancer: should we recommend screening for thyroid cancer in breast cancer patients","volume":"24","author":"Wang","year":"2023","journal-title":"BMC Genomics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184492","article-title":"The role of blood microbiome in the development of thyroid cancer in breast cancer survivors","volume":"15","author":"An","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12905-023-02205-6","article-title":"Role of breast cancer screening in the overdiagnosis of thyroid cancer: results from a cross-sectional nationwide survey","volume":"23","author":"Lee","year":"2023","journal-title":"BMC Womens Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10069-6","article-title":"The co-occurrence of both breast and differentiated thyroid cancer: incidence, association and clinical implications for daily practice","volume":"22","author":"Piek","year":"2022","journal-title":"BMC Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1136120","article-title":"The clinical and genetic features in patients coexisting primary breast and thyroid cancers","volume":"14","author":"Fu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1138149","article-title":"Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study","volume":"14","author":"Tan","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/78630","article-title":"The mammary gland iodide transporter is expressed during lactation and in breast cancer","volume":"6","author":"Tazebay","year":"2000","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01982-5","article-title":"Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment","volume":"127","author":"Tran","year":"2022","journal-title":"Br J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.983996","article-title":"Case report: Lymph node metastases of breast cancer and thyroid cancer encountered in axilla","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2023.2249702","article-title":"Thyroid hormone enhances estrogen-mediated proliferation and cell cycle regulatory pathways in steroid receptor-positive breast cancer","volume":"23","author":"Wahdan-Alaswad","year":"2024","journal-title":"Cell Cycle"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26825","article-title":"Breast and thyroid cancer: a multicenter study with Accrual to Clinical Trials Network","volume":"125","author":"Peckham","year":"2022","journal-title":"J Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12020133","article-title":"Association between thyroid cancer and breast cancer: two longitudinal follow-up studies using a national health screening cohort","volume":"12","author":"Jin","year":"2022","journal-title":"J Pers Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9547","article-title":"Characteristics and survival of patients with metachronous or synchronous double primary Malignancies: breast and thyroid cancer","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12874-021-01347-1","article-title":"Machine learning in medicine: a practical introduction to natural language processing","volume":"21","author":"Harrison","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","article-title":"Machine learning applications in cancer prognosis and prediction","volume":"13","author":"Kourou","year":"2014","journal-title":"Comput Struct Biotechnol J"},{"key":"B18","volume-title":"Breast tumours","year":"2019"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/09622802231151220","article-title":"Minimum sample size for developing a multivariable prediction model using multinomial logistic regression","volume":"32","author":"Pate","year":"2023","journal-title":"Stat Methods Med Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6486-6","article-title":"Eighth edition of the AJCC Cancer Staging Manual: Breast cancer","volume":"25","author":"Giuliano","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"key":"B22","volume-title":"Guidelines for breast cancer diagnosis and treatment by Chinese Society of Clinical Oncology (CSCO) 2024","author":"Jiang","year":"2024"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American Pathologists guideline update","volume":"41","author":"Wolff","year":"2023","journal-title":"J Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.21037\/tbcr-24-31","article-title":"Chinese Society of Clinical Oncology (CSCO) breast cancer guidelines 2024","volume":"5","author":"Li","year":"2024","journal-title":"Transl Breast Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.21608\/ZUMJ.2019.9705.11040","article-title":"Comparison impact of conventional versus conformal radiotherapy techniques on thyroid in breast cancer irradiation","volume":"25","author":"El-Sawy","year":"2019","journal-title":"Zagazig Univ Med J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/jmss.JMSS_10_19","article-title":"The measurement of thyroid absorbed dose by Gafchromic\u2122 EBT2 film and changes in thyroid hormone levels following radiotherapy in patients with breast cancer","volume":"10","author":"Ansari","year":"2020","journal-title":"J Med Signals Sens"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2016.17.10.4577","article-title":"Thyroid function after postoperative radiation therapy in patients with breast cancer","volume":"17","author":"Wolny-Rokicka","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ijc.29907","article-title":"The contribution of radiotherapy to subsequent thyroid cancer risk may be confined to a subgroup of breast cancer patients","volume":"138","author":"Lin","year":"2016","journal-title":"Int J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-018-1875-7","article-title":"Evaluation of thyroid gland as an organ at risk after breast cancer radiotherapy: a systematic review and meta-analysis","volume":"20","author":"Darvish","year":"2018","journal-title":"Clin Transl Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18502\/fbt.v9i3.9650","article-title":"Impact of different beam energies on the incidence of thyroid cancer in breast cancer radiotherapy","volume":"9","author":"Ghaznavi","year":"2022","journal-title":"Front BioMed Technol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.34172\/ddj.1605","article-title":"Dysfunction of thyroid and parathyroid after breast cancer radiation therapy in Bandarabbas Omid Radiotherapy Center","author":"Ashouri Taziani","year":"2024","journal-title":"Dis Diagn"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4103\/jmss.JMSS_12_18","article-title":"Estimation of the thyroid secondary cancer risk on the patient of standard breast external beam radiotherapy","volume":"8","author":"Momeni","year":"2018","journal-title":"J Med Signals Sensors"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0150","article-title":"The association between serum TSH concentration and thyroid cancer","volume":"16","author":"Boelaert","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.1976.03270250013005","article-title":"Thyroid supplements and breast cancer","volume":"236","author":"Barnes","year":"1976","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5737\/23688076344477","article-title":"Evaluation of the thyroid and hypothyroid function after postoperative radiation therapy among breast cancer patients","volume":"34","author":"Rahimi","year":"2024","journal-title":"Can Oncol Nurs J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3456-6","article-title":"The association between breast cancer and thyroid cancer: a meta-analysis","volume":"152","author":"Joseph","year":"2015","journal-title":"Breast Cancer Res Treat"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1772910\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:26:29Z","timestamp":1773725189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1772910\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":38,"alternative-id":["10.3389\/fonc.2026.1772910"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1772910","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"article-number":"1772910"}}